Clinical implementation of preemptive pharmacogenomics in psychiatryResearch in context

Summary: Background: Pharmacogenomics (PGx) holds promise to revolutionize modern healthcare. Although there are several prospective clinical studies in oncology and cardiology, demonstrating a beneficial effect of PGx-guided treatment in reducing adverse drug reactions, there are very few such stu...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Maria Skokou, Kariofyllis Karamperis, Margarita-Ioanna Koufaki, Evangelia-Eirini Tsermpini, Maria-Theodora Pandi, Stavroula Siamoglou, Panagiotis Ferentinos, Marina Bartsakoulia, Theodora Katsila, Christina Mitropoulou, George P. Patrinos, Konstantinos Assimakopoulos, Eleni Georgila, Philippos Gourzis, Aikaterini Karaivazoglou, Olympia Prodromaki, George Rigas, Georgia Voukelatou, Vassiliki Zacharopoulou, Evangelia Barba, Konstantina Chalikiopoulou, Dimitra Dedousi, Georgia Emmanouil, Panagiotis Giannopoulos, Ouliana Ivantsik, Marina Kalogeropoulou, Manoussos E. Kambouris, Filippos Kanellakis, Alexandra Kolliopoulou, Panagiotis Kollios, Zoi Kordou, Ioannis Liopetas, Efrossyni Mendrinou, Konstantinos Mitropoulos, Georgia-Chryssa Samiou, Theano Stamopoulou, Andreas Stathoulias, Apostolos Stratopoulos, Athina Tsikrika, Athanassios Douzenis, Charilaos Gerassimou, Maria-Angeliki Voziki, Athanassios Vozikis
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-03-01
Saila:	EBioMedicine
Gaiak:	Preemptive pharmacogenomics Clinical implementation Schizophrenia Major depressive disorder Bipolar disorder Cost-effectiveness
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2352396424000446
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!